Page 7 - தலை ஆஃப் வெளிப்புறம் தகவல்தொடர்புகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

EQS-Adhoc: Lonza Group AG: Lonza Announces Expansion Plans for Next-Generation Mammalian Manufacturing Facilities in Visp (CH) and Portsmouth (US)

EQS-Adhoc: Lonza Group AG: Lonza Announces Expansion Plans for Next-Generation Mammalian Manufacturing Facilities in Visp (CH) and Portsmouth (US) Lonza Announces Expansion Plans for Next-Generation Mammalian Manufacturing Facilities in Visp (CH) and Portsmouth (US) 06-May-2021 / 07:01 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this announcement. Lonza will invest approximately CHF 850 million to build two new state-of-the-art mammalian facilities and respond to customer demand regarding capacity, life cycle management and speed to market A new large-scale facility with the latest manufacturing technology in Visp (CH), will expand capacity by six 20,000L bioreactors to meet increasing market demand for biologics

Switzerland generalUnited kingdomDirk oehlersPierre alain ruffieuxJean christophe hyvertHead of external communicationsLonza group ltdLonza group ag keyLonza groupGroup news serviceEqs groupSwiss exchangeAnnounces expansion plansSwiss alpsAd hocசுவிட்சர்லாந்து ஜநரல்

Lonza Announces Expansion Plans for Next-Generation Mammalian Manufacturing Facilities in Visp (CH)

Lonza Group AG / Key word(s): Expansion 06-May-2021 / 07:01 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this announcement. Lonza will invest approximately CHF 850 million to build two new state-of-the-art mammalian facilities and respond to customer demand regarding capacity, life cycle management and speed to market A new large-scale facility with the latest manufacturing technology in Visp (CH), will expand capacity by six 20,000L bioreactors to meet increasing market demand for biologics Small-scale, single-use technology facility planned for Portsmouth (US) to support customers scaling clinical to commercial manufacturing with capacity for up to eight 2,000L bioreactors

Switzerland generalUnited kingdomDirk oehlersPierre alain ruffieuxJean christophe hyvertLonza group ltdHead of external communicationsLonza group ag keyLonza groupSwiss alpsசுவிட்சர்லாந்து ஜநரல்ஒன்றுபட்டது கிஂக்டம்தலை ஆஃப் வெளிப்புறம் தகவல்தொடர்புகள்சுவிஸ் ஆல்ப்ஸ்

QIAGEN N V : QIAGEN Exceeds Outlook in First Quarter 2021 Results, Reaffirms Sales Growth and Profitability Outlook for Full-Year 2021

(2) Q1 2021 net sales rise 52% (48% CER) to $567.2 million, exceeds outlook for at least 45% CER growth; adj. EPS up 94% to $0.66 ($0.65 CER), exceeds outlook for ~$0.60-0.62 CER 16% CER growth to $364 million from non-COVID product groups, represent 64% of total sales, while COVID-19 product group sales rise 186% CER to $203 million Q1 2021 operating cash flow rises over 700% to $128.6 million, free cash flow of $82.3 million Reaffirming full-year 2021 outlook for ~18-20% CER net sales growth and ~$2.42-2.46 CER adjusted diluted EPS QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced strong results of operations for the first quarter of 2021, exceeding the goals for net sales and adjusted earnings per share.

Thierry bernardJohn gilardiRobert reitzeThomas theuringerPhoebe lohExchange commissionHead of external communicationsCorporate communicationsLife sciencesUs securities exchangeFrankfurt prime standardChief executive officerLyme diseaseMolecular diagnosticsExchange actAnnual report

IFS s Q1 hits significant markers with recurring revenue over 80% of software revenue, cloud revenue growth at 102% and representing over 50% of recurring revenue

IFS s Q1 hits significant markers with recurring revenue over 80% of software revenue, cloud revenue growth at 102% and representing over 50% of recurring revenue News provided by Share this article Share this article LONDON, April 27, 2021 /PRNewswire/ IFS, the global enterprise applications company, today announced its financial results for the first quarter-January to March of 2021. After a strong 2020, Q1 results point to a continuation of the growth trajectory across the entire business and specifically in recurring revenue, cloud revenue and service management revenue. IFS s position as the global vendor of choice for companies transforming their business models away from selling products towards selling services and outcomes is validated by its Q1 performance and the triple-digit growth of its service management business at 103 percent.

City ofUnited kingdomConstance mincNatalie suttonDarren roosIt service managementMoment of serviceHead of external communicationsAxios systemsFinancial officerSwedish kronaநகரம் ஆஃப்ஒன்றுபட்டது கிஂக்டம்நிலைத்தன்மை மிங்க்நடாலி சுட்டன்டேரன் ரூஸ்

IFS s Q1 hits significant markers with recurring revenue over 80% of software revenue, cloud revenue growth at 102% and representing over 50% of recurring revenue

IFS s Q1 hits significant markers with recurring revenue over 80% of software revenue, cloud revenue growth at 102% and representing over 50% of recurring revenue
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomConstance mincNatalie suttonDarren roosIt service managementMoment of serviceHead of external communicationsAxios systemsFinancial officerSwedish kronaநகரம் ஆஃப்ஒன்றுபட்டது கிஂக்டம்நிலைத்தன்மை மிங்க்நடாலி சுட்டன்டேரன் ரூஸ்